Obstetrics and Gynecology

1046 soru

Soru 341Soru →

Match each gynecologic or gestational neoplasm with its characteristic clinical tumor marker and classic histologic or clinical finding.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Yolk sac (endodermal sinus) tumor
Granulosa cell tumor
Choriocarcinoma
Dysgerminoma

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Yolk sac tumor matches with elevated AFP; Granulosa cell tumor matches with estrogen, inhibin, and Call-Exner bodies; Choriocarcinoma matches with elevated beta-hCG and lung metastasis; Dysgerminoma matches with elevated LDH and 'fried egg' cells.
Correct matching pairs the neoplasm with its unique pathognomonic diagnostic feature: AFP/Schiller-Duval bodies for yolk sac tumors, estrogen/inhibin/Call-Exner bodies for granulosa cell tumors, beta-hCG/lung metastasis for choriocarcinomas, and LDH/'fried egg' cells for dysgerminomas.

Adım Adım Çözüm

1
Identify the characteristic tumor marker and histology for Yolk sac tumors.
Yolk sac tumors are associated with elevated AFP and Schiller-Duval bodies.
These are the primary diagnostic hallmarks of endodermal sinus tumors.
2
Identify the characteristic tumor marker and histology for Granulosa cell tumors.
Granulosa cell tumors secrete estrogen/inhibin and have Call-Exner bodies.
As sex cord-stromal tumors, they produce sex hormones, presenting differently from germ cell tumors.
3
Identify the characteristic tumor marker and clinical presentation for Choriocarcinoma.
Choriocarcinoma presents with markedly elevated beta-hCG and aggressive hematogenous spread to the lungs.
It is a malignant tumor of trophoblastic tissue that readily invades blood vessels.
4
Identify the characteristic tumor marker and histology for Dysgerminomas.
Dysgerminomas are associated with elevated LDH and uniform 'fried egg' cells.
This tumor is the ovarian counterpart to testicular seminoma and shares identical histologic features.

Anahtar Kavram

Ovarian and Gestational Tumor Markers and Histopathology
Soru 342Soru →

A patient in her second pregnancy, having had one previous uncomplicated term birth, presents to the labor and delivery unit at 38 weeks and 4 days of gestation. She is experiencing regular, painful uterine contractions. Her vital signs are within normal limits. Cervical examination reveals 7 cm of dilation and 100% effacement with the fetal vertex at 0 station. External electronic fetal monitoring displays a baseline heart rate of 140/min with moderate variability. Over the next 20 minutes, the tracing shows recurrent, abrupt drops in the fetal heart rate to 90/min, each lasting approximately 40 seconds before returning rapidly to baseline. These drops vary in their timing relative to the peaks of the uterine contractions. What is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Assist the patient into a lateral decubitus position

Cevap

Assist the patient into a lateral decubitus position
The correct answer involves assisting the patient into a lateral decubitus position. The patient's fetal monitor tracing describes recurrent variable decelerations, characterized by an abrupt decrease in the fetal heart rate (onset to nadir in less than 30 seconds) that varies in its onset, depth, and duration relative to uterine contractions. Variable decelerations are caused by umbilical cord compression. The initial step in management is intrauterine resuscitation to alleviate this compression. Maternal repositioning (such as moving to the left or right lateral decubitus position) is the most appropriate first action, as it can quickly shift the fetus off the umbilical cord. If repositioning fails, an amnioinfusion may be considered for recurrent variable decelerations.

Adım Adım Çözüm

1
Interpret the fetal heart rate tracing.
The tracing shows recurrent, abrupt decelerations with timing that varies relative to uterine contractions.
Identifying the specific pattern differentiates between early, late, and variable decelerations.
2
Determine the etiology of the decelerations.
Abrupt, variable decelerations are classically caused by umbilical cord compression.
Understanding the underlying pathophysiology guides the appropriate clinical intervention.
3
Select the most appropriate initial management.
The first-line management for umbilical cord compression is intrauterine resuscitation, starting with maternal repositioning.
Maternal repositioning shifts the fetus and often immediately relieves the pressure on the umbilical cord.

Anahtar Kavram

Recurrent variable decelerations are caused by umbilical cord compression and are initially managed with intrauterine resuscitation, such as maternal repositioning.
Tahmini Süre:1m 0s
Soru 343Soru →

An otherwise healthy 27-year-old nulliparous woman arrives at the emergency department with severe, worsening lower abdominal pain and subjective fevers over the past three days. She also reports a foul-smelling vaginal discharge. Her temperature is 39.2°C (102.6°F), blood pressure is 108/68 mmHg, and pulse is 114/min. On physical examination, she exhibits marked cervical motion tenderness and guarding in the bilateral lower quadrants. Bimanual examination reveals a severely tender, fluctuant 6-cm mass in the left adnexa. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the standard evaluation and step-wise management of this patient, from initial triage to intervention for potential medical failure.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with ruling out pregnancy, followed by confirming the diagnosis via ultrasound, initiating primary medical management with IV antibiotics, and holding percutaneous drainage in reserve for medical failure.
The optimal management of a reproductive-age female with acute pelvic pain and a mass must invariably begin with a pregnancy test to rule out ectopic pregnancy. Once ruled out, pelvic ultrasound is the imaging modality of choice to visualize a suspected tubo-ovarian abscess (TOA). Following confirmation, hospitalization with intravenous broad-spectrum antibiotics is the standard first-line treatment. Invasive procedures like percutaneous or surgical drainage are reserved for patients who fail to improve after 48-72 hours of medical therapy, or for those presenting with a ruptured TOA or hemodynamic instability.

Adım Adım Çözüm

1
Rule out pregnancy
Perform a urine hCG test
Ectopic pregnancy is a life-threatening differential diagnosis for acute pelvic pain and an adnexal mass that must be excluded immediately.
2
Visualize the adnexa
Perform a transvaginal ultrasound
Imaging differentiates a tubo-ovarian abscess from uncomplicated pelvic inflammatory disease or other adnexal pathology (e.g., ovarian torsion).
3
Provide definitive first-line therapy
Admit for IV broad-spectrum antibiotics
Medical management with broad-spectrum IV antibiotics resolves up to 70% of unruptured tubo-ovarian abscesses without the need for surgery.
4
Escalate therapy if necessary
Perform image-guided percutaneous drainage
Drainage is indicated only if the patient remains febrile or symptomatic after an adequate 48-to-72-hour trial of intravenous antibiotics.

Anahtar Kavram

Step-wise management of a suspected tubo-ovarian abscess (TOA)
Soru 344Soru →

A 28-year-old multiparous patient experiences severe hemorrhage and hypovolemic shock immediately following the vaginal delivery of a 4,100 g4,100\text{ g} neonate. During the third stage of labor, aggressive umbilical cord traction was applied before complete placental separation. Physical examination reveals a firm, round, red mass protruding through the vaginal introitus, and the uterine fundus is no longer palpable in the lower abdomen. Profuse vaginal bleeding is ongoing.

Arrange the following management steps for this obstetric emergency in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential management of acute uterine inversion is: 1) Discontinue uterotonics, 2) Administer a uterine relaxant, 3) Perform manual replacement, 4) Restart uterotonic therapy, and 5) Proceed to laparotomy if manual replacement fails.
Acute uterine inversion requires a strict chronological sequence to resolve the mechanical obstruction and prevent life-threatening hemorrhage. The sequence begins by halting any agents that contract the uterus, followed by active relaxation of the myometrium. Once relaxed, the uterus is manually pushed back into position. Only after anatomical restoration is confirmed should contracting agents be administered to secure hemostasis. Surgery is strictly reserved for refractory cases.

Adım Adım Çözüm

1
Discontinue all uterotonics
Prevents further cervical constriction
Avoids trapping the inverted fundus outside the pelvic cavity, which would make reduction impossible.
2
Administer a uterine relaxant (e.g., nitroglycerin or terbutaline)
Relaxes the myometrium and cervical ring
Prepares the anatomical structures to allow the fundus to pass back through the cervix.
3
Perform manual replacement (Johnson maneuver)
Restores normal uterine anatomy
Solves the primary mechanical obstruction by pushing the fundus back into the pelvic cavity.
4
Restart aggressive uterotonic therapy
Contracts the replaced uterus
Maintains the correct anatomical position and achieves hemostasis to stop the life-threatening hemorrhage.
5
Proceed to exploratory laparotomy (Huntington/Haultain procedure)
Surgical correction of the inversion
Provides definitive management if all conservative manual measures are unsuccessful.

Anahtar Kavram

Chronological algorithmic management of acute puerperal uterine inversion

Alternatif Yöntem

If manual replacement fails and surgery is delayed, hydrostatic replacement (O'Sullivan's technique) can be attempted. This involves instilling warm saline into the vagina while blocking the introitus, using fluid pressure to push the fundus upward.
Tahmini Süre:3m 0s
Soru 345Soru →

A 67-year-old G1P1 is evaluated for a two-week history of mild pelvic cramping and scant, brownish vaginal discharge. Her last menstrual period was 15 years ago. Her medical history includes severe osteoporosis, for which she takes raloxifene, and hypothyroidism, for which she takes levothyroxine. Her BMI is 22 kg/m². On speculum examination, the vaginal mucosa appears pale and thin, with a small amount of old blood in the vaginal vault and at the cervical os. Bimanual examination reveals a small, anteverted uterus and no adnexal masses. Transvaginal ultrasonography demonstrates a homogeneously thickened endometrium measuring 6 mm. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Endometrial biopsy

Cevap

Endometrial biopsy
The correct approach for evaluating postmenopausal bleeding involves either an initial endometrial biopsy or a transvaginal ultrasound (TVUS). If TVUS is performed and reveals an endometrial thickness greater than 4 mm, an endometrial biopsy is mandatory to obtain a histologic diagnosis. Despite the patient exhibiting physical signs of atrophic vaginitis and taking a medication that does not increase endometrial cancer risk (raloxifene), the objective finding of a 6 mm endometrial stripe requires direct tissue sampling to definitively rule out endometrial carcinoma.

Adım Adım Çözüm

1
Identify the primary clinical problem.
A 67-year-old postmenopausal woman presenting with vaginal bleeding.
Any episode of bleeding after menopause is highly abnormal and must be assumed to be endometrial cancer until proven otherwise.
2
Analyze the diagnostic findings provided.
Transvaginal ultrasound (TVUS) reveals an endometrial thickness of 6 mm.
According to standard guidelines, an endometrial stripe > 4 mm in a postmenopausal woman with bleeding has a sufficiently high risk of malignancy to mandate histologic evaluation.
3
Assess potential confounding factors in the vignette.
The patient has signs of vaginal atrophy and is taking raloxifene, while her BMI is low (22 kg/m²).
Vaginal atrophy is a common benign cause of bleeding, but the thickened endometrium supersedes this finding. Unlike tamoxifen, raloxifene does not increase the risk of endometrial cancer, but its use does not exempt the patient from a biopsy when the > 4 mm threshold is met. The lack of classic risk factors (like obesity) does not change the management algorithm.
4
Determine the definitive next step.
Endometrial biopsy.
Direct tissue sampling is required to definitively rule out endometrial carcinoma or atypical hyperplasia.

Anahtar Kavram

In a postmenopausal woman presenting with vaginal bleeding, an endometrial thickness greater than 4 mm on transvaginal ultrasound absolutely mandates an endometrial biopsy to rule out malignancy, regardless of coexisting benign findings such as atrophic vaginitis.
Soru 346Soru →

A 28-year-old woman presents to the clinic for a routine well-woman examination. She had a levonorgestrel-releasing intrauterine device (IUD) placed two years ago and reports being highly satisfied with the method. During the speculum examination, the physician is unable to visualize the IUD strings at the external cervical os. The patient is completely asymptomatic, reporting no abdominal pain, fever, or unexpected vaginal bleeding. Arrange the following diagnostic and management steps in the most appropriate chronological sequence to address the missing IUD strings.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing missing IUD strings is to first exclude pregnancy, then attempt to locate the strings in the endocervix, followed by a pelvic ultrasound if unsuccessful, and finally an abdominal radiograph if the ultrasound is negative.
The management of missing IUD strings in an asymptomatic patient follows a strict algorithmic approach to safely locate the device while minimizing invasive testing. The first step is always to exclude pregnancy with a beta-hCG test, as an enlarging pregnant uterus can pull the strings upward, and pregnancy must be ruled out before inserting any instruments into the cervix. Next, the physician should gently probe the endocervical canal with a cytobrush, as the strings most commonly retract just inside the external os and can often be easily retrieved. If the strings cannot be recovered from the canal, a transvaginal ultrasound is indicated as the first-line imaging modality to determine if the IUD is present and correctly positioned within the uterine cavity. Finally, if the ultrasound fails to demonstrate the IUD in the uterus, an abdominal and pelvic X-ray must be obtained to distinguish between an unnoticed vaginal expulsion and a dangerous uterine perforation with intra-abdominal device migration.

Adım Adım Çözüm

1
Identify the clinical problem.
The patient is asymptomatic but has non-visible IUD strings on speculum examination.
Requires a stepwise approach to locate the device or confirm its expulsion safely.
2
Determine the absolute first step.
Urine pregnancy test.
Rules out an unrecognized pregnancy, which can alter uterine size and draw strings upward, and ensures safety before any cervical manipulation.
3
Select the most appropriate initial physical intervention.
Probe the endocervical canal with a cytobrush.
Strings frequently retract just inside the os; a cytobrush can easily and non-invasively retrieve them back into the vagina.
4
Determine the first-line imaging modality if physical localization fails.
Transvaginal ultrasound.
Safely and accurately visualizes the uterine cavity to confirm whether the IUD is correctly placed, malpositioned, or absent.
5
Select the definitive test if the IUD is absent on ultrasound.
Abdominal and pelvic radiograph.
Differentiates between a device that was expelled unnoticed by the patient and one that perforated the uterus and migrated into the peritoneal cavity.

Anahtar Kavram

Management algorithm for missing intrauterine device (IUD) strings
Soru 347Soru →

A 24-year-old primigravid woman at 39 weeks gestation is in the second stage of labor. The fetus is in a vertex, occiput anterior presentation. As the fetal head navigates through the maternal bony pelvis, it undergoes a series of predictable, adaptive positional changes. Arrange the following cardinal movements of labor in the correct chronological order as they typically occur.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of the cardinal movements of labor is Engagement, Flexion, Internal rotation, Extension, and External rotation.
The cardinal movements of labor describe the adaptations the fetal head must make to pass through the maternal pelvis. The correct chronological sequence is: Engagement (head enters pelvic inlet), Descent (continuous throughout), Flexion (head chin-to-chest to present smallest diameter), Internal rotation (sagittal suture aligns with anteroposterior pelvic diameter), Extension (head delivers under symphysis pubis), External rotation/restitution (head untwists to align with shoulders), and Expulsion (delivery of anterior and posterior shoulders).

Adım Adım Çözüm

1
Identify the clinical scenario
The patient is in the second stage of normal labor with an occiput anterior presentation.
Understanding the normal physiologic process of a vertex vaginal delivery is required to determine the sequence of movements.
2
Determine the initial pelvic entry
Engagement is the first movement, as the biparietal diameter enters the pelvic inlet.
The fetus must enter the true pelvis before further movements can occur.
3
Sequence the subsequent fetal head adaptations
Flexion occurs as the head meets pelvic resistance, followed by internal rotation to navigate the midpelvis.
These positional changes present the smallest cephalic diameter to the birth canal and align the head optimally.
4
Sequence the delivery and realignment movements
Extension allows the head to be delivered under the pubic symphysis, followed by external rotation (restitution) to align with the shoulders.
This completes the mechanism of delivery for the fetal head and prepares the shoulders for expulsion.

Anahtar Kavram

Normal physiologic adaptations of the fetal head during vaginal delivery (cardinal movements of labor).
Soru 348Soru →

A 29-year-old nulliparous woman at 39 weeks gestation is evaluated in the labor and delivery unit due to a concerning fetal heart rate tracing. Her pregnancy has been uncomplicated. She was admitted in active labor and her cervix is currently 7 cm dilated and 100% effaced, with the fetal presenting part at +1 station. Uterine contractions are occurring every 2 to 3 minutes, each lasting approximately 60 seconds. Spontaneous rupture of membranes occurred 2 hours ago, revealing clear fluid. The continuous electronic fetal monitor demonstrates a baseline heart rate of 135/min with moderate variability. With each of the last four contractions, there is an abrupt decrease in the fetal heart rate to 85/min that reaches its nadir in 15 seconds and resolves quickly as the contraction subsides. The decelerations last approximately 45 seconds each. The patient is promptly repositioned to the left lateral decubitus position and administered an intravenous fluid bolus. However, the subsequent three contractions demonstrate the exact same fetal heart rate pattern. Maternal blood pressure is 118/76 mm Hg and pulse is 88/min. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiation of an amnioinfusion

Cevap

Initiation of an amnioinfusion
The correct answer is the initiation of an amnioinfusion. This patient's fetal heart rate tracing demonstrates recurrent variable decelerations, defined as visually apparent abrupt decreases in heart rate (onset to nadir less than 30 seconds) lasting between 15 seconds and 2 minutes, occurring with more than 50% of uterine contractions. Variable decelerations are typically caused by umbilical cord compression, which can occur due to oligohydramnios, cord prolapse, or normal descent of the fetus. Initial intrauterine resuscitation for recurrent variable decelerations includes maternal repositioning (to relieve mechanical cord compression) and intravenous fluid boluses. Because this patient's decelerations persist despite these first-line maneuvers, the next best step is an amnioinfusion. This procedure involves instilling normal saline or lactated Ringer's solution into the uterine cavity via an intrauterine pressure catheter. The added fluid artificially increases amniotic fluid volume, which cushions the umbilical cord, reduces the incidence of cord compression, and decreases the need for cesarean delivery.

Adım Adım Çözüm

1
Analyze the fetal heart rate tracing
Abrupt decreases in the fetal heart rate lasting 45 seconds that occur with every contraction indicate recurrent variable decelerations.
Accurate interpretation of the fetal heart rate pattern is necessary to identify the underlying pathophysiology, which in this case is umbilical cord compression.
2
Evaluate the response to initial resuscitative measures
The decelerations persist despite maternal repositioning and administration of an intravenous fluid bolus.
First-line interventions were appropriately attempted but failed to relieve the mechanical cord compression.
3
Determine the next step in the management algorithm
Select amnioinfusion to artificially replace amniotic fluid and cushion the umbilical cord.
Amnioinfusion is the standard second-line therapy for recurrent variable decelerations to prevent the need for an emergency cesarean delivery.

Anahtar Kavram

Recurrent variable decelerations unresponsive to initial resuscitative measures (repositioning, intravenous fluids) should be managed with amnioinfusion to relieve umbilical cord compression.
Soru 349Soru →

A 3333-year-old woman, G3P2, at 3636 weeks gestation is brought to the emergency department after a high-speed motor vehicle collision. She complains of severe, constant abdominal pain. She is fully conscious but extremely anxious and reiterates her religious objection to receiving any blood products, providing a signed advance directive that explicitly refuses transfusions under all circumstances. Her blood pressure is 82/5082/50 mm Hg, heart rate is 128128/min, and respiratory rate is 2222/min. Abdominal examination reveals a rigid, exquisitely tender uterus, and fetal parts are easily palpable just beneath the maternal abdominal wall. A focused assessment with sonography for trauma (FAST) exam shows a large amount of free fluid in the hepatorenal recess. Arterial blood gas on room air shows a pH of 7.447.44, pCO 2_2 of 2929 mm Hg, pO 2_2 of 9898 mm Hg, and HCO 3−_3^- of 2020 mEq/L. Hemoglobin is 10.410.4 g/dL. Fetal heart tracing shows a baseline of 170170/min, absent variability, and recurrent late decelerations. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Proceed immediately to exploratory laparotomy and cesarean delivery using non-blood volume expanders

Cevap

Proceed immediately to exploratory laparotomy and cesarean delivery using non-blood volume expanders
The patient has experienced a traumatic uterine rupture, indicated by maternal hemorrhagic shock, easily palpable fetal parts outside the uterine contour, and a Category III fetal heart tracing. Immediate exploratory laparotomy and cesarean delivery are necessary to control the hemorrhage and deliver the fetus. Because she is a competent adult with a clear, signed advance directive refusing blood products, her autonomy must be respected. The surgical team must proceed with alternative resuscitation methods, such as crystalloid volume expanders or a cell saver (if acceptable to her beliefs), but cannot force a blood transfusion.

Adım Adım Çözüm

1
Evaluate maternal hemodynamic stability and fetal status following major trauma.
The patient is in hemorrhagic shock (BP 82/5082/50 mm Hg, positive FAST) with severe fetal compromise (Category III tracing).
Immediate recognition of life-threatening hemorrhage is necessary to triage the patient to the operating room.
2
Diagnose the specific obstetric complication causing the presentation.
Uterine rupture is diagnosed based on the mechanism of injury, rigid abdomen, and easily palpable fetal parts outside the normal uterine contour.
Traumatic uterine rupture results in massive intra-abdominal hemorrhage and rapid fetal asphyxia, mandating emergent surgical intervention.
3
Determine the appropriate intervention while respecting ethical and legal constraints.
Emergency laparotomy utilizing non-blood volume expanders is selected.
A competent pregnant patient has the autonomy to refuse blood products. This refusal must be honored even in a life-threatening emergency that threatens maternal or fetal survival.

Anahtar Kavram

Management of traumatic uterine rupture in a hemodynamically unstable patient with an explicit refusal of blood products.
Soru 350Soru →

A 10-year-old girl is brought to the clinic by her mother for a routine well-child visit. The mother asks about what to expect regarding her daughter's physical development over the next few years. The physician explains the typical progression of female puberty. Arrange the following physiological milestones of normal female puberty in their typical chronological sequence of occurrence, from earliest to latest.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological order is: Thelarche, Pubarche, Peak height velocity, and finally Menarche.
Normal female puberty follows a predictable sequence dictated by the maturation of the hypothalamic-pituitary-gonadal axis and the adrenal glands. Thelarche (breast development) is typically the first physical sign, occurring at an average age of 10. Pubarche (pubic hair development) usually follows shortly after. The maximum growth spurt (peak height velocity) occurs midway through puberty (Tanner stage III to IV), preceding menarche. Menarche is a late event, typically occurring 2 to 2.5 years after thelarche.

Adım Adım Çözüm

1
Identify the initial physical sign of puberty in females.
Thelarche is typically the first milestone.
Ovarian estrogen production begins as the hypothalamic-pituitary-gonadal axis awakens, leading to breast budding.
2
Determine the subsequent milestone.
Pubarche follows thelarche.
Adrenal androgens stimulate the growth of pubic and axillary hair.
3
Identify the timing of the maximum growth spurt.
Peak height velocity occurs next.
Synergistic effects of estrogen and growth hormone maximize linear growth prior to menarche.
4
Determine the final major pubertal milestone.
Menarche is the final step.
Menstruation begins once the hypothalamic-pituitary-ovarian axis reaches maturity, typically 2 to 2.5 years after thelarche.

Anahtar Kavram

Sequence of normal female pubertal development
Soru 351Soru →

A 26-year-old pregnant woman, currently at 35 weeks of gestation, arrives at the emergency department via ambulance after being the restrained driver in a high-speed motor vehicle collision. She complains of severe, unremitting abdominal pain and reports a sudden onset of dark vaginal bleeding. Her past medical history is unremarkable. Her blood pressure is 82/50 mmHg82/50 \text{ mmHg}, heart rate is 132/min132/\text{min}, and respiratory rate is 24/min24/\text{min}. Physical examination reveals a rigid, diffusely tender, and "woody" uterus. Initial laboratory studies show a hemoglobin level of 8.5 g/dL8.5 \text{ g/dL}. Continuous electronic fetal monitoring demonstrates a baseline heart rate of 95/min95/\text{min} with absent variability and recurrent late decelerations. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Perform an immediate laparotomy with cesarean delivery

Cevap

Perform an immediate laparotomy with cesarean delivery
This patient presents with the classic triad of placental abruption (abruptio placentae): sudden-onset vaginal bleeding, severe abdominal pain, and a rigid, hypertonic uterus. Her presentation following a high-speed motor vehicle collision is highly suggestive of a traumatic abruption. Furthermore, she is in hypovolemic shock, and the fetal heart rate tracing is Category III (fetal bradycardia with absent variability and late decelerations), indicating severe fetal hypoxia. In the setting of severe placental abruption with maternal hemodynamic instability and a non-reassuring fetal status, the most appropriate next step is concurrent aggressive maternal resuscitation (intravenous fluids, blood products) and an immediate laparotomy with cesarean delivery to control the hemorrhage and deliver the distressed fetus.

Adım Adım Çözüm

1
Assess maternal hemodynamic status and the physical examination findings.
The patient is in hypovolemic shock (82/50 mmHg82/50 \text{ mmHg}, 132/min132/\text{min}) with a rigid, woody uterus and dark vaginal bleeding following trauma.
These findings are highly indicative of a severe, life-threatening placental abruption with massive concealed and revealed hemorrhage.
2
Evaluate the fetal status based on the continuous electronic fetal monitoring.
The tracing shows fetal bradycardia (95/min95/\text{min}), absent variability, and late decelerations (a Category III tracing).
This indicates severe fetal hypoxia and acidemia secondary to uteroplacental insufficiency caused by the abruption.
3
Determine the definitive next best step in management.
Immediate surgical intervention (exploratory laparotomy with cesarean delivery) alongside concurrent maternal resuscitation.
Both the mother and the fetus are hemodynamically unstable and at imminent risk of death; delaying for imaging or conservative management is absolutely contraindicated.

Anahtar Kavram

Management of severe placental abruption complicated by maternal hemodynamic instability and fetal distress requires immediate surgical delivery and aggressive maternal resuscitation.
Soru 352Soru →

A 6161-year-old female presents to the physician with a chief complaint of vaginal spotting that began 22 days ago. She experienced menopause at age 5151. Her medical history includes hypertension, obesity, and type 2 diabetes mellitus. A speculum examination demonstrates a normal-appearing vagina and cervix, with a small amount of blood exiting the external cervical os. Pelvic sonography is performed and reveals an endometrial stripe thickness of 9 mm9 \text{ mm}. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Endometrial sampling

Cevap

Endometrial sampling
Endometrial sampling is the definitive and most appropriate next step for this patient. She presents with postmenopausal bleeding and has multiple risk factors for endometrial cancer, including obesity and type 2 diabetes mellitus (which contribute to a hyperestrogenic state). Furthermore, her pelvic sonography reveals an endometrial stripe of 9 mm9 \text{ mm}. In postmenopausal women, an endometrial thickness >4 mm>4 \text{ mm} requires tissue diagnosis to rule out endometrial hyperplasia and carcinoma.

Adım Adım Çözüm

1
Identify the primary clinical problem and patient demographic.
The patient is a 6161-year-old postmenopausal female presenting with new-onset vaginal bleeding (postmenopausal bleeding).
Recognizing postmenopausal bleeding is critical because it is a cardinal sign of endometrial cancer until proven otherwise.
2
Evaluate the results of the initial diagnostic imaging.
Pelvic sonography demonstrates an endometrial thickness of 9 mm9 \text{ mm}.
In a postmenopausal woman, an endometrial stripe thickness greater than 4 mm4 \text{ mm} is considered abnormal and highly suspicious for hyperplasia or malignancy.
3
Determine the definitive next step in management based on imaging findings.
Tissue diagnosis via endometrial sampling is indicated.
Because the endometrium is abnormally thickened, direct tissue evaluation is required to rule out endometrial carcinoma before initiating any treatment or electing observation.

Anahtar Kavram

Postmenopausal bleeding with an endometrial stripe >4 mm>4 \text{ mm} on ultrasound requires immediate endometrial sampling to rule out malignancy.
Soru 353Soru →

A 36-year-old woman comes to the clinic for evaluation of severe vulvar itching and vaginal burning that began 5 days ago. Over the past year, she has had four similar episodes. Each prior episode was treated with a single dose of oral fluconazole, which provided only transient partial relief before her symptoms recurred. Her medical history includes type 2 diabetes mellitus. Current medications include metformin and sitagliptin, though she admits to frequently missing doses. Her most recent hemoglobin A1c is 9.4%. Vital signs are temperature 37.0°C (98.6°F), blood pressure 122/78 mmHg, heart rate 78/min, and respiratory rate 14/min. Pelvic examination demonstrates pronounced vulvar erythema and edema with visible excoriations. A moderate amount of thick, white, adherent discharge is present in the vaginal vault. The cervix is visually normal with no bleeding or discharge from the external os, and bimanual examination is unremarkable with no cervical motion tenderness. Vaginal pH is 4.3. Wet mount microscopy with 10% potassium hydroxide preparation reveals numerous small budding yeast cells but is notably negative for pseudohyphae. Which of the following is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravaginal boric acid therapy

Cevap

Intravaginal boric acid therapy
The correct answer is intravaginal boric acid therapy. This patient has recurrent vulvovaginal candidiasis (RVVC), defined as four or more episodes in a single year. Her poorly controlled diabetes mellitus is a significant risk factor for atypical fungal infections. While the vast majority of RVVC is caused by Candida albicans, her failure to fully respond to multiple prior courses of fluconazole and the specific microscopic finding of budding yeast without pseudohyphae strongly point to a non-albicans species, most commonly Candida glabrata. Unlike C. albicans, C. glabrata lacks the ability to form pseudohyphae and has high rates of intrinsic resistance to azole antifungals. Consequently, the first-line recommended treatment for azole-refractory C. glabrata vulvovaginitis is intravaginal boric acid therapy for 14 days.

Adım Adım Çözüm

1
Analyze the patient's presenting symptoms and clinical history.
The patient has recurrent vulvovaginitis (4 or more episodes per year) in the setting of poorly controlled diabetes mellitus.
To identify the clinical syndrome and recognize risk factors for infections with atypical pathogens.
2
Evaluate the response to prior therapies and laboratory findings.
The patient failed multiple courses of fluconazole, and the wet mount shows budding yeast but notably lacks pseudohyphae.
To determine the specific etiology. The absence of pseudohyphae and clinical azole resistance strongly point to a non-albicans species, specifically Candida glabrata.
3
Select the most appropriate evidence-based therapy.
Intravaginal boric acid is selected.
Boric acid is the recommended first-line treatment for azole-refractory, non-albicans Candida vulvovaginitis.

Anahtar Kavram

Recurrent, fluconazole-refractory vulvovaginal candidiasis showing budding yeast without pseudohyphae is typically caused by Candida glabrata, which requires treatment with intravaginal boric acid.
Soru 354Soru →

Match each complex clinical presentation of a gynecologic infection with the most appropriate next step in management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with severe vaginal pruritus and pseudohyphae on wet mount. She has had four laboratory-confirmed episodes in the past 12 months, all temporarily responsive to single-dose fluconazole.
A 42-year-old woman with a 7-year history of copper intrauterine device use presents with chronic pelvic pain and weight loss. Endometrial biopsy reveals branching, Gram-positive, anaerobic bacilli with sulfur granules.
A 24-year-old primigravida at 12 weeks gestation is diagnosed with Chlamydia trachomatis cervicitis. She is treated appropriately with a macrolide antibiotic and is currently asymptomatic.
A 21-year-old woman requires inpatient admission for pelvic inflammatory disease due to intractable vomiting. She has a history of anaphylaxis to penicillin. She is hemodynamically stable.
A 30-year-old woman admitted for pelvic inflammatory disease complicated by a 7-cm tubo-ovarian abscess has persistent fever and worsening pelvic pain despite 72 hours of appropriate intravenous antibiotics.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match the specific clinical scenario with its unique, guideline-concordant management step.
Each specific clinical scenario presents a complication or exception to basic management guidelines. Matching requires recognizing the criteria for recurrent vulvovaginal candidiasis, the presentation and treatment of pelvic actinomycosis, the pregnancy-specific requirement for a Chlamydia test of cure, the safe PID regimen for penicillin-anaphylactic patients, and the indications for procedural intervention in a non-resolving tubo-ovarian abscess.

Adım Adım Çözüm

1
Analyze the recurrent candidiasis presentation.
Identify that the patient meets the criteria for recurrent vulvovaginal candidiasis (≥4\geq 4 episodes in 12 months).
Single-dose therapy is insufficient for recurrent disease; induction and 6-month maintenance are required.
2
Evaluate the patient with an IUD and sulfur granules.
Diagnose pelvic Actinomycosis.
Branching Gram-positive rods with sulfur granules in an IUD user confirms the diagnosis, necessitating IUD removal and penicillin G.
3
Assess the pregnant patient treated for Chlamydia.
Identify the need for a test of cure.
Unlike non-pregnant adults, pregnant women must have a test of cure 3-4 weeks after therapy to ensure eradication and prevent neonatal complications.
4
Determine the PID inpatient regimen for a patient with penicillin anaphylaxis.
Select clindamycin plus gentamicin.
Standard inpatient cephalosporin-based regimens are contraindicated in severe IgE-mediated penicillin allergies.
5
Manage the tubo-ovarian abscess (TOA) non-responsive to antibiotics.
Escalate to percutaneous drainage.
Lack of clinical improvement (fever, pain) after 72 hours of IV antibiotics indicates failure of medical management, necessitating source control.

Anahtar Kavram

Management of complicated gynecologic infections requires adapting standard guidelines to specific contexts: recurrent disease, foreign bodies (IUD), pregnancy, severe drug allergies, and medical therapy failure.
Soru 355Soru →

A 28-year-old nulligravid woman presents to the clinic with a 4-month history of rapidly worsening facial hair growth, deepening of her voice, and male-pattern baldness. She has not had a menstrual period for the past 5 months. Previously, her menses were regular, occurring every 28 days. Her body mass index is 23 kg/m2. Vital signs are within normal limits. Pelvic examination reveals clitoromegaly and a normal-sized, non-tender uterus. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum testosterone and dehydroepiandrosterone sulfate levels

Cevap

Measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels.
The correct next step is evaluating serum androgen levels. Rapid-onset virilization (clitoromegaly, voice deepening, male-pattern baldness) over a short period of time is a classic red flag for an androgen-secreting tumor. Measuring testosterone (which is typically elevated in ovarian tumors) and dehydroepiandrosterone sulfate (which is exclusively produced by the adrenal glands and elevated in adrenal tumors) is necessary to confirm the hyperandrogenic state and localize the source before pursuing targeted imaging.

Adım Adım Çözüm

1
Analyze the patient's presentation
The patient has a 4-month history of amenorrhea coupled with severe, rapidly progressive virilization (clitoromegaly, deepening of voice, male-pattern baldness).
Identifying the severity and timeline of hyperandrogenic symptoms is critical for differentiating benign from malignant etiologies.
2
Determine the most likely underlying etiology based on the timeline
Rapid-onset virilization is highly suspicious for an androgen-secreting neoplasm rather than a chronic condition like polycystic ovary syndrome.
Tumors produce extreme amounts of hormones autonomously and quickly, leading to severe physical changes that benign disorders typically do not cause.
3
Select the appropriate diagnostic workup
Measure serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels.
Elevated testosterone suggests an ovarian source (e.g., Sertoli-Leydig cell tumor), whereas elevated DHEAS points to an adrenal source. This guides subsequent imaging.

Anahtar Kavram

Rapid-onset hyperandrogenism with signs of virilization (clitoromegaly, voice deepening) requires immediate evaluation for an androgen-secreting tumor of the ovary or adrenal gland by measuring testosterone and DHEAS levels.
Soru 356Soru →

Match each patient's clinical presentation, laboratory findings, and histologic description with the most likely corresponding ovarian neoplasm.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 16-year-old girl presents with pelvic pain. Evaluation reveals a solid adnexal mass. Labs show markedly elevated lactate dehydrogenase (LDH). Histopathology reveals sheets of uniform cells with clear cytoplasm and central nuclei.
A 19-year-old woman presents with rapid abdominal enlargement. Evaluation shows a large solid ovarian mass and significantly elevated alpha-fetoprotein (AFP). Biopsy reveals Schiller-Duval bodies.
A 64-year-old woman presents with postmenopausal bleeding. Ultrasound shows a thickened endometrial stripe and a unilateral complex ovarian mass. Labs show elevated inhibin levels. Biopsy reveals Call-Exner bodies.
A 26-year-old woman presents with deepening of her voice, male-pattern hair growth, and clitoromegaly. She has a solid ovarian mass. Labs show elevated testosterone. Histopathology reveals Reinke crystals.
A 32-year-old woman presents with palpitations, weight loss, and heat intolerance. TSH is suppressed, and free T4 is elevated. Radioiodine scan shows uptake localized to the pelvis in a complex adnexal mass.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are: 16-year-old with elevated LDH matches Dysgerminoma; 19-year-old with elevated AFP matches Yolk sac tumor; 64-year-old with elevated inhibin matches Granulosa cell tumor; 26-year-old with virilization matches Sertoli-Leydig cell tumor; 32-year-old with hyperthyroidism matches Struma ovarii.
Each clinical presentation contains classic pathognomonic features of specific ovarian neoplasms. Dysgerminoma uniquely correlates with elevated LDH and 'fried egg' uniform cells. Yolk sac tumor strictly correlates with elevated AFP and Schiller-Duval bodies. Granulosa cell tumor correlates with elevated inhibin, estrogen excess (causing postmenopausal bleeding), and Call-Exner bodies. Sertoli-Leydig cell tumor correlates with testosterone excess (causing virilization) and Reinke crystals. Struma ovarii correlates with hyperthyroidism due to ectopic thyroid tissue in the pelvis.

Adım Adım Çözüm

1
Analyze each clinical vignette for patient age, symptoms, and specific tumor markers.
Identify unique markers such as LDH, AFP, inhibin, testosterone, and thyroxine in each respective patient.
Ovarian neoplasms have highly specific biochemical profiles that dictate their clinical manifestations.
2
Correlate the histopathological findings with known ovarian tumor subtypes.
Match Schiller-Duval bodies, Call-Exner bodies, Reinke crystals, and uniform 'fried egg' cells to their corresponding tumors.
Histopathology provides the definitive diagnosis for classifying complex ovarian masses.
3
Synthesize the clinical, laboratory, and pathological data to confirm the final pairings.
All five distinct clinical profiles are successfully matched to the five major specialized ovarian neoplasms.
Combining multiple diagnostic modalities ensures accuracy in identifying these varied tumors.

Anahtar Kavram

Characteristics, tumor markers, and histology of ovarian neoplasms
Soru 357Soru →

Match each clinical presentation of third-trimester obstetric complications with its most likely diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A grand multiparous patient at term undergoing a trial of labor after cesarean suddenly reports sharp, tearing pelvic pain. Contractions abruptly cease, and the fetal presenting part has retracted on pelvic exam.
Shortly after artificial rupture of membranes, a patient at 38 weeks gestation experiences moderate vaginal bleeding without uterine discomfort. The fetal monitor immediately displays a sinusoidal pattern and severe bradycardia.
A pregnant individual at 33 weeks gestation with a history of severe preeclampsia complains of unremitting, knife-like abdominal pain. Exam shows a hypertonic, board-like uterus and moderate dark-colored vaginal bleeding.
A patient at 32 weeks gestation reports experiencing a sudden gush of bright red vaginal blood that soaked her clothes, completely without any associated cramping or abdominal pain. Her uterus is soft to palpation.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The sudden tearing pain with loss of fetal station matches Uterine rupture; the painless bleeding upon membrane rupture with fetal bradycardia matches Vasa previa; the painful bleeding with a hypertonic uterus matches Placental abruption; and the painless bleeding with a soft uterus matches Placenta previa.
Antepartum hemorrhage etiologies are distinguished clinically: Placenta previa presents with painless bright red bleeding; Vasa previa presents with painless bleeding and immediate fetal distress at amniotomy; Placental abruption presents with painful dark bleeding and uterine tetany; and Uterine rupture presents with sudden severe pain, loss of contractions, and loss of fetal station.

Adım Adım Çözüm

1
Evaluate the presence or absence of abdominal pain associated with the bleeding.
Painful presentations align with uterine rupture and placental abruption. Painless presentations align with placenta previa and vasa previa.
Pain is a primary differentiating factor in third-trimester bleeding, distinguishing maternal/fetal vascular exposure from muscular tearing or retroplacental hematoma formation.
2
Analyze the timing of fetal heart rate changes and membrane rupture in the painless bleeding scenarios.
Bleeding immediately after membrane rupture with rapid fetal distress identifies vasa previa.
In vasa previa, the ruptured vessels are fetal, leading to rapid exsanguination and immediate fetal bradycardia upon membrane rupture.
3
Differentiate the painful bleeding presentations by uterine tone and contraction pattern.
A hypertonic, rigid uterus indicates abruption, while cessation of contractions and loss of fetal station indicates uterine rupture.
Abruption causes concealed bleeding that irritates the myometrium (tetany), whereas rupture physically disrupts the myometrium, halting effective contractions.

Anahtar Kavram

Clinical differentiation of third-trimester bleeding etiologies based on pain, uterine tone, and fetal heart rate changes.
Soru 358Soru →

A 61-year-old woman, gravida 3, para 3, presents to the gynecology clinic reporting a three-day history of light vaginal spotting. Her last menstrual period occurred 10 years ago, and she denies any postmenopausal bleeding prior to this episode. Her medical history is significant for type 2 diabetes mellitus, chronic hypertension, and obesity (BMI 38 kg/m^2). Current medications include metformin, lisinopril, and a daily multivitamin. Vital signs are within normal limits. Pelvic examination demonstrates pale, thinned vaginal mucosa with decreased rugosity. A small amount of dark blood is visible at the external cervical os. Bimanual examination reveals a normal-sized, mobile uterus without adnexal masses. A transvaginal ultrasound reveals an endometrial echo complex measuring 9 mm in thickness. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Endometrial tissue sampling

Cevap

The correct answer is Endometrial tissue sampling.
The correct answer is endometrial tissue sampling. Any postmenopausal woman presenting with vaginal bleeding requires prompt evaluation to rule out endometrial carcinoma. The initial workup typically involves a transvaginal ultrasound (TVUS). In a postmenopausal patient with bleeding, an endometrial echo complex (stripe) thickness of ≤\leq 4 mm has a high negative predictive value for malignancy, and tissue sampling can often be deferred. However, this patient has an endometrial thickness of 9 mm, which is markedly abnormal. Furthermore, she possesses classic risk factors for estrogen-dependent (Type I) endometrial cancer, including obesity, type 2 diabetes, and advanced age. Peripheral aromatization of androgens in adipose tissue leads to chronic, unopposed estrogen exposure, causing endometrial proliferation. The definitive next step is histologic evaluation of the uterine lining to diagnose or exclude atypical hyperplasia or carcinoma.

Adım Adım Çözüm

1
Identify the primary clinical problem and patient demographic.
The patient is a 61-year-old postmenopausal woman presenting with new-onset vaginal bleeding.
Postmenopausal bleeding is considered a cardinal sign of endometrial carcinoma until proven otherwise.
2
Evaluate the patient's risk factors for the suspected disease.
The patient has multiple risk factors for type I endometrial cancer: advanced age, obesity (BMI 38 kg/m^2), and type 2 diabetes mellitus.
Obesity causes increased peripheral conversion of androgens to estrone by adipose tissue aromatase, leading to chronic unopposed estrogen exposure.
3
Interpret the diagnostic imaging findings in the context of the clinical presentation.
Transvaginal ultrasound reveals an endometrial thickness of 9 mm.
In a postmenopausal woman with vaginal bleeding, an endometrial stripe greater than 4 mm is abnormal and warrants histologic evaluation.
4
Determine the definitive next step in management.
The patient requires immediate histologic evaluation via endometrial tissue sampling.
To definitively rule out endometrial hyperplasia or carcinoma, tissue must be obtained for pathologic review before any medical or definitive surgical treatment is initiated.

Anahtar Kavram

Evaluation of Postmenopausal Bleeding
Soru 359Soru →

A 31-year-old nulliparous patient at 41 weeks gestation is admitted to the labor and delivery unit for induction of labor due to postterm pregnancy. She is currently receiving an intravenous oxytocin infusion. Her temperature is 37.0°C (98.6°F), blood pressure is 122/78 mmHg, and pulse is 88/min. Cervical examination reveals 5 cm dilation, 80% effacement, and -1 station. The external fetal monitor displays a baseline heart rate of 135/min with moderate variability. Over the past 40 minutes, the tracing reveals recurrent, gradual decreases in the fetal heart rate that begin consistently after the peak of each uterine contraction and do not return to baseline until the contraction has ended. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinue the intravenous oxytocin infusion

Cevap

Discontinue the intravenous oxytocin infusion
The patient's fetal heart rate tracing describes late decelerations, characterized by a gradual decrease in fetal heart rate that begins after the peak of a uterine contraction and returns to baseline after the contraction has finished. Late decelerations are a sign of uteroplacental insufficiency and transient fetal hypoxemia. The most appropriate initial step in management is to perform intrauterine resuscitation to improve placental blood flow. This includes immediately discontinuing uterotonic agents (such as oxytocin) to reduce uterine activity, placing the patient in a lateral decubitus position to relieve aortocaval compression, administering an intravenous fluid bolus, and providing supplemental oxygen.

Adım Adım Çözüm

1
Interpret the fetal heart rate (FHR) tracing described in the clinical vignette.
The FHR pattern shows late decelerations.
The decelerations are described as gradual and beginning after the peak of the uterine contraction, returning to baseline after the contraction ends.
2
Identify the underlying pathophysiology of this specific FHR pattern.
Uteroplacental insufficiency.
Late decelerations are classically caused by decreased blood flow and oxygen exchange across the placenta during contractions.
3
Determine the immediate next step in management.
Initiate intrauterine resuscitation by discontinuing oxytocin.
Removing uterine stimulation decreases contraction frequency and intensity, immediately improving placental perfusion and fetal oxygenation.

Anahtar Kavram

Intrapartum management of late fetal heart rate decelerations
Soru 360Soru →

Seeking evaluation for bilateral pelvic discomfort, a female patient in her early thirties is seen at an ambulatory care clinic. The pain has steadily worsened over the past three days and is associated with a thick, yellow vaginal discharge. She has no significant past medical history and takes no daily medications other than a combined oral contraceptive pill. Her vital signs include a blood pressure of 118/76118/76 mmHg, a heart rate of 8888/min, and a temperature of 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}). Abdominal examination reveals mild lower quadrant tenderness without guarding or rebound. Pelvic examination demonstrates mucopurulent discharge at the cervical os. Bimanual examination elicits significant pain upon manipulation of the cervix as well as bilateral adnexal tenderness. A point-of-care urine pregnancy test is negative. She is able to tolerate oral fluids in the clinic without nausea. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administration of a single dose of intramuscular ceftriaxone, along with a 14-day course of oral doxycycline and oral metronidazole

Cevap

Administration of a single dose of intramuscular ceftriaxone, along with a 14-day course of oral doxycycline and oral metronidazole
The patient's clinical presentation is classic for acute pelvic inflammatory disease (PID). Because she is hemodynamically stable, tolerating oral intake, not pregnant, and lacks severe systemic illness or signs of a tubo-ovarian abscess, she qualifies for outpatient management. The standard-of-care outpatient regimen consists of intramuscular ceftriaxone (to cover Neisseria gonorrhoeae), oral doxycycline (to cover Chlamydia trachomatis), and oral metronidazole (to provide robust coverage against anaerobic organisms frequently involved in the polymicrobial pathogenesis of PID).

Adım Adım Çözüm

1
Analyze the clinical presentation and physical examination findings.
The patient has fever, pelvic pain, mucopurulent cervical discharge, cervical motion tenderness, and adnexal tenderness.
These findings fulfill the diagnostic criteria for acute pelvic inflammatory disease (PID).
2
Determine the appropriate setting for care (inpatient vs. outpatient).
The patient is non-pregnant, lacks peritoneal signs or suspected tubo-ovarian abscess (TOA), and can tolerate oral fluids.
Patients with mild-to-moderate PID without indications for hospitalization can be safely managed in an outpatient setting.
3
Select the guideline-concordant empiric outpatient antibiotic regimen.
The correct regimen is a single dose of intramuscular ceftriaxone combined with 14 days of oral doxycycline and oral metronidazole.
This combination ensures comprehensive coverage of Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobes, aligning with current public health guidelines.

Anahtar Kavram

Outpatient management of Pelvic Inflammatory Disease (PID) requires empiric coverage for N. gonorrhoeae, C. trachomatis, and anaerobes using intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.
ÖncekiSayfa 18 / 53Sonraki
Obstetrics and Gynecology Alıştırma Soruları — USMLE Step 2 CK — Sayfa 18 | Examkin